Wu G S, Burns T F, Zhan Y, Alnemri E S, El-Deiry W S
Howard Hughes Medical Institute, Department of Medicine, and Cancer Center, University of Pennsylvania School of Medicine, Philadelphia 19104-6148, USA.
Cancer Res. 1999 Jun 15;59(12):2770-5.
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptors are members of the tumor necrosis factor superfamily. TRAIL selectively kills cancer cells but not normal cells. We report here the cloning of the mouse homologue of the TRAIL receptor KILLER/DR5 (MK). The cDNA of MK is 1146 bp in length and encodes a protein of 381 amino acids. MK contains an extracellular cysteine-rich domain, a transmembrane domain, and a cytoplasmic death-domain characteristic of Fas, tumor necrosis factor, and human TRAIL receptors. MK is highly homologous and binds TRAIL with similar affinity as human DR4 and KILLER/DR5. MK induces apoptosis in mouse and human cells and inhibits colony growth of NIH3T3 cells. Expression of MK is p53-dependent and up-regulated by tumor suppressor p53 and by DNA damaging agents in mouse cells undergoing apoptosis. This is the first report describing a mouse TRAIL receptor gene and also demonstrating that the p53-dependent regulation of KILLER/DR5-mediated apoptosis is conserved between human and mouse.
肿瘤坏死因子相关凋亡诱导配体(TRAIL)及其受体是肿瘤坏死因子超家族的成员。TRAIL能选择性地杀死癌细胞而不损伤正常细胞。我们在此报告了TRAIL受体KILLER/DR5(MK)的小鼠同源物的克隆。MK的cDNA长度为1146 bp,编码一个由381个氨基酸组成的蛋白质。MK含有一个富含半胱氨酸的细胞外结构域、一个跨膜结构域以及一个具有Fas、肿瘤坏死因子和人TRAIL受体特征的细胞质死亡结构域。MK与人类DR4和KILLER/DR5高度同源,并且以相似的亲和力结合TRAIL。MK能诱导小鼠和人类细胞凋亡,并抑制NIH3T3细胞的集落生长。MK的表达依赖于p53,在经历凋亡的小鼠细胞中,它受肿瘤抑制因子p53和DNA损伤剂的上调。这是首次描述小鼠TRAIL受体基因的报告,同时也证明了KILLER/DR5介导的凋亡的p53依赖性调控在人和小鼠之间是保守的。